Elsevier

Annals of Oncology

Volume 31, Supplement 4, September 2020, Page S1161
Annals of Oncology

LBA30 INOVATYON study: Randomized phase III international study comparing trabectedin/PLD followed by platinum at progression vs carboplatin/PLD in patients with recurrent ovarian cancer progressing within 6-12 months after last platinum line

https://doi.org/10.1016/j.annonc.2020.08.2260Get rights and content
Under an Elsevier user license
open archive

Cited by (0)